Two Sigma Advisers
FMTX

Two Sigma Advisers’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Two Sigma Advisers’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-74,700
Closed -$1.49M – 2791
2022
Q3 		$1.49M Sell
74,700
-87,300
-54% -$1.15M ﹤0.01% 1328
2022
Q2 		$1.12M Buy
162,000
+82,100
+103% +$576K ﹤0.01% 1542
2022
Q1 		$743K Buy
+79,900
New +$850K ﹤0.01% 1793

Two Sigma Advisers's FMTX Position: Q4 2022 in Review

Two Sigma Advisers sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 74,700 shares — an estimated $1.49M sold.

Two Sigma Advisers first reported a position in FMTX in Q1 2022 and held it in 3 quarters. The position peaked at $1.49M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Two Sigma Advisers reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 74,700 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $1.49M.
  • Two Sigma Advisers first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Two Sigma Advisers's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.49M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.